Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.32 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.32 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.32 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.32 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.32 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.32 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.32 |
| ▸ | PPM1B | O75688 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23092043 | 1.00 | ALDH1A1 (0.36) | ALDH1A1LMNAMAPTKDM4EMEN1 | |
| SCHEMBL29402949 | 0.85 | ALDH1A1 (0.34) | ALDH1A1TP53ALOX15 | |
| SCHEMBL10886647 | 0.84 | HSP90AA1 (0.36) | ALDH1A1LMNAMAPTKDM4E | |
| SCHEMBL9579824 | 0.84 | LMNA (0.36) | ALDH1A1LMNAMAPTKDM4EMEN1 | |
| SCHEMBL2264463 | 0.81 | ALDH1A1 (0.40) | ALDH1A1LMNAMAPTKDM4EMEN1 | |
| SCHEMBL11455549 | 0.78 | ALDH1A1 (0.32) | ALDH1A1ALOX15 | |
| SCHEMBL11455547 | 0.78 | ALDH1A1 (0.32) | ALDH1A1ALOX15 | |
| SCHEMBL14248383 | 0.75 | ALDH1A1 (0.41) | ALDH1A1LMNAMAPTKDM4EMEN1 | |
| SCHEMBL11447479 | 0.75 | CYP1A2 (0.32) | — | |
| SCHEMBL11447481 | 0.75 | CYP1A2 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 920 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111051483-B | Esters and ethers of 2, 4-tetramethyl cyclobutane-1, 3-diol as fragrance chemicals | 巴斯夫欧洲公司 | 2025-01-24 | — | — | CN | claimed |
| US-12187978-B2 | Use of (3-acetoxy-2,2-dimethyl-propyl) acetate in combination with (3-hydroxy-2,2-dimethyl-propyl) acetate as an aroma chemical | BASF SE (DE) | 2025-01-07 | — | — | US | claimed |
| US-20220274913-A1 | PROCESS FOR MANUFACTURING A SUBSTITUTED CYCLOHEXANECARBONITRILE | SOLVAY SA (BE) | 2022-09-01 | — | — | US | claimed |
| EP-4028383-A1 | PROCESS FOR MANUFACTURING A SUBSTITUTED CYCLOHEXANECARBONITRILE | SOLVAY SA (BE) | 2022-07-20 | — | — | EP | claimed |
| CN-114401944-A | Process for making substituted cyclohexanecarbonitriles | 索尔维公司 | 2022-04-26 | — | — | CN | claimed |
| CN-109152711-B | Method for producing perfume capsules with improved surfactant stability | 西姆莱斯股份公司 | 2021-10-22 | — | — | CN | claimed |
| CN-113056547-A | Jasmine alcohol | 西姆莱斯有限公司 | 2021-06-29 | — | — | CN | claimed |
| WO-2021048364-A1 | PROCESS FOR MANUFACTURING A SUBSTITUTED CYCLOHEXANECARBONITRILE | SOLVAY SA (BE) | 2021-03-18 | — | — | WO | claimed |
| EP-3507352-A1 | PRODUCT COMPRISING A PLASTIC CONTAINER AND A SUBSTANCE COMPOSITION | Symrise AG (DE) | 2019-07-10 | — | — | EP | claimed |
| EP-3423028-A1 | METHOD FOR THE PRODUCTION OF SCENT CAPSULES WITH IMPROVED SURFACTANT STABLITY | Symrise AG (DE) | 2019-01-09 | — | — | EP | claimed |
| EP-1697386-A1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | General Electric Company A Corporation of the State of New York (US) | 2006-09-06 | — | — | EP | claimed |
| US-20060166857-A1 | 4,8-Dimethyl-7-nonen-2-one and 4,8-dimethylnonan-2-one used as perfumes | SYMRISE GMBH & CO. KG (DE) | 2006-07-27 | — | — | US | claimed |
| WO-2005066186-A2 | CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | GENERAL ELECTRIC COMPANY (US) | 2005-07-21 | — | — | WO | claimed |
| WO-2005066187-A1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | GENERAL ELECTRIC COMPANY (US) | 2005-07-21 | — | — | WO | claimed |
| US-20050136021-A1 | Active-releasing cyclic siloxanes | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-06-23 | — | — | US | claimed |
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-06-23 | — | — | US | claimed |
| US-4570648-A | Flavorants containing esters of 2,3,6,6-tetramethylcyclohexenyl carboxylic acids | GIVAUDAN CORPORATION (US) | 1986-02-18 | — | — | US | claimed |
| US-4474687-A | PERFUMES, FLAYORS | GIVAUDAN CORPORATION (US) | 1984-10-02 | — | — | US | claimed |
| US-4375001-A | ORGANOLEPTIC AGENT | GIVAUDAN CORPORATION | 1983-02-22 | — | — | US | claimed |
| EP-0021100-B1 | CYCLOHEXENES ON THEIR OWN OR MIXED WITH (IV), PROCESS FOR PREPARATION OF (I), USE OF (I), OPTIONALLY (I+IV), AS AROMATIC AND/OR PERFUMERY SUBSTANCES, AND COMPOSITIONS OF AROMATIC AND/OR PERFUMERY SUBSTANCES THAT CONTAIN (I), OPTIONALLY (I+IV) | L. GIVAUDAN & CIE Société Anonyme (CH) | 1982-11-17 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | F9, RPL39, ECPAS | ALDH1A1 44/4885LMNA 568/4885MAPT 815/4885 |
| US-20050136021-A1 | Active-releasing cyclic siloxanes | F9, RPL39, ALDH16A1 | ALDH1A1 57/4885LMNA 882/4885MAPT 1453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.